Study title: Ketotifen fumarate and olopatadine hydrochloride in the treatment of allergic conjunctivitis: a real-world comparison of efficacy and ocular comfort. Ganz M, Koll E, Gausche J, Detjen P, Orfan N. Adv Ther. 2003 Mar-Apr;20(2):79-91. Ketotifen fumarate and olopatadine hydrochloride in the treatment of allergic conjunctivitis: a real-world comparison of efficacy and ocular comfort. Ganz M, Koll E, Gausche J, Detjen P, Orfan N. Adv Ther. 2003 Mar-Apr;20(2):79-91.
Type of medicine: Centrally authorised medicines | |||||
Therapeutic area: Eye Diseases | |||||
Brands: Please see report, Please see report, Please see report, Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: olopatadine | |||||
ATC code: S01GX 09 | |||||
Document link: Ketotifen fumarate and olopatadine hydrochloride in the treatment of allergic conjunctivitis a real-world comparison of efficacy and ocular comfort... | |||||
Document date: 2011-09-27 | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: CLINICAL | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |